Target Cell Cyclophilin A Modulates Human Immunodeficiency Virus Type 1 Infectivity

ABSTRACT The peptidyl-prolyl isomerase cyclophilin A (CypA) increases the kinetics by which human immunodeficiency virus type 1 (HIV-1) spreads in tissue culture. This was conclusively demonstrated by gene targeting in human CD4+ T cells, but the role of CypA in HIV-1 replication remains unknown. Though CypA binds to mature HIV-1 capsid protein (CA), it is also incorporated into nascent HIV-1 virions via interaction with the CA domain of the Gag polyprotein. These findings raised the possibility that CypA might act at multiple steps of the retroviral life cycle. Disruption of the CA-CypA interaction, either by the competitive inhibitor cyclosporine (CsA) or by mutation of CA residue G89 or P90, suggested that producer cell CypA was required for full virion infectivity. However, recent studies indicate that CypA within the target cell regulates HIV-1 infectivity by modulating Ref1- or Lv1-mediated restriction. To examine the relative contribution to HIV-1 replication of producer cell CypA and target cell CypA, we exploited multiple tools that disrupt the HIV-1 CA-CypA interaction. These tools included the drugs CsA, MeIle4-CsA, and Sanglifehrin; CA mutants exhibiting decreased affinity for CypA or altered CypA dependence; HeLa cells with CypA knockdown by RNA interference; and Jurkat T cells homozygous for a deletion of the gene encoding CypA. Our results clearly demonstrate that target cell CypA, and not producer cell CypA, is important for HIV-1 CA-mediated function. Inhibition of HIV-1 infectivity resulting from virion production in the presence of CsA occurs independently of the CA-CypA interaction or even of CypA.

[1]  J. Luban,et al.  Selection for Loss of Ref1 Activity in Human Cells Releases Human Immunodeficiency Virus Type 1 from Cyclophilin A Dependence during Infection , 2004, Journal of Virology.

[2]  J. Luban,et al.  Lv1 Inhibition of Human Immunodeficiency Virus Type 1 Is Counteracted by Factors That Stimulate Synthesis or Nuclear Translocation of Viral cDNA , 2004, Journal of Virology.

[3]  J. Luban,et al.  Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1 , 2004, Nature.

[4]  C. M. Owens,et al.  The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys , 2004, Nature.

[5]  V. Bond,et al.  Chimeric Human Immunodeficiency Virus Type 1 (HIV-1) Virions Containing HIV-2 or Simian Immunodeficiency Virus Nef Are Resistant to Cyclosporine Treatment , 2004, Journal of Virology.

[6]  M. Magnasco,et al.  Production of ribosome components in effector CD4+ T cells is accelerated by TCR stimulation and coordinated by ERK-MAPK. , 2003, Immunity.

[7]  P. Bieniasz,et al.  Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors , 2003, Nature Medicine.

[8]  P. Pandolfi,et al.  As2O3 Enhances Retroviral Reverse Transcription and Counteracts Ref1 Antiviral Activity , 2003, Journal of Virology.

[9]  I. Verma,et al.  Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Y. Takeuchi,et al.  Restriction of lentivirus in monkeys , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Summers,et al.  Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein , 2002, Nature Structural Biology.

[12]  D. A. Bosco,et al.  Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Bernards,et al.  A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.

[14]  H. Kräusslich,et al.  Differential dependence of the infectivity of HIV-1 group O isolates on the cellular protein cyclophilin A. , 2002, Virology.

[15]  M. Zurini,et al.  Sanglifehrin A, a Novel Cyclophilin-Binding Compound Showing Immunosuppressive Activity with a New Mechanism of Action , 2001, The Journal of Immunology.

[16]  J. Luban,et al.  Cyclophilin A regulates HIV‐1 infectivity, as demonstrated by gene targeting in human T cells , 2001, The EMBO journal.

[17]  Y. Takeuchi,et al.  A conserved mechanism of retrovirus restriction in mammals. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Wesley I. Sundquist,et al.  Image reconstructions of helical assemblies of the HIV-1 CA protein , 2022 .

[19]  K. Memmert,et al.  Sanglifehrins A, B, C and D, novel cyclophilin-binding compounds isolated from Streptomyces sp. A92-308110. I. Taxonomy, fermentation, isolation and biological activity. , 1999, The Journal of antibiotics.

[20]  J. Kallen,et al.  Sanglifehrins A, B, C and D, novel cyclophilin-binding compounds isolated from Streptomyces sp. A92-308110. II. Structure elucidation, stereochemistry and physico-chemical properties. , 1999, The Journal of antibiotics.

[21]  U. Schubert,et al.  Cyclophilin A incorporation is not required for human immunodeficiency virus type 1 particle maturation and does not destabilize the mature capsid. , 1999, Virology.

[22]  H. Kräusslich,et al.  In vitro assembly properties of wild-type and cyclophilin-binding defective human immunodeficiency virus capsid proteins in the presence and absence of cyclophilin A. , 1999, Virology.

[23]  R. Bristow,et al.  Human cyclophilin has a significantly higher affinity for HIV-1 recombinant p55 than p24. , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[24]  E. Freed,et al.  HIV-1 gag proteins: diverse functions in the virus life cycle. , 1998, Virology.

[25]  C. Aiken Mechanistic independence of Nef and cyclophilin A enhancement of human immunodeficiency virus type 1 infectivity. , 1998, Virology.

[26]  J. Luban,et al.  Human Immunodeficiency Virus Type 1 Replication Is Modulated by Host Cyclophilin A Expression Levels , 1998, Journal of Virology.

[27]  D. Streblow,et al.  Cyclophilin a modulates processing of human immunodeficiency virus type 1 p55Gag: mechanism for antiviral effects of cyclosporin A. , 1998, Virology.

[28]  P. Stewart,et al.  Cryoelectron Microscopic Examination of Human Immunodeficiency Virus Type 1 Virions with Mutations in the Cyclophilin A Binding Loop , 1998, Journal of Virology.

[29]  J. Canon,et al.  Cells with High Cyclophilin A Content Support Replication of Human Immunodeficiency Virus Type 1 Gag Mutants with Decreased Ability To Incorporate Cyclophilin A , 1998, Journal of Virology.

[30]  W. Sundquist,et al.  Crystal structure of cyclophilin A complexed with a binding site peptide from the HIV‐1 capsid protein , 1997, Protein science : a publication of the Protein Society.

[31]  H. Göttlinger,et al.  Transfer of the HIV-1 cyclophilin-binding site to simian immunodeficiency virus from Macaca mulatta can confer both cyclosporin sensitivity and cyclosporin dependence. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Borsetti,et al.  Active-site residues of cyclophilin A are crucial for its incorporation into human immunodeficiency virus type 1 virions , 1997, Journal of virology.

[33]  U. Reimer,et al.  Conformational state of a 25-mer peptide from the cyclophilin-binding loop of the HIV type 1 capsid protein. , 1997, The Biochemical journal.

[34]  C. Aiken Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A , 1997, Journal of virology.

[35]  W. Sundquist,et al.  Molecular recognition in the HIV-1 capsid/cyclophilin A complex. , 1997, Journal of molecular biology.

[36]  J. Luban,et al.  The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein , 1997, Journal of virology.

[37]  Y. Zhao,et al.  Cyclophilin A complexed with a fragment of HIV-1 gag protein: insights into HIV-1 infectious activity. , 1997, Structure.

[38]  J. Luban Absconding with the Chaperone: Essential Cyclophilin–Gag Interaction in HIV-1 Virions , 1996, Cell.

[39]  W. Sundquist,et al.  Crystal Structure of Human Cyclophilin A Bound to the Amino-Terminal Domain of HIV-1 Capsid , 1996, Cell.

[40]  J. Luban,et al.  Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. , 1996, Virology.

[41]  J. Luban,et al.  Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A , 1996, Journal of virology.

[42]  R. Naviaux,et al.  The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses , 1996, Journal of virology.

[43]  J. Luban,et al.  Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization , 1996, Journal of virology.

[44]  J. Luban,et al.  Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses , 1996, Journal of virology.

[45]  J. Luban,et al.  Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription , 1996, Journal of virology.

[46]  W. Phares,et al.  Spontaneous mutations in the human immunodeficiency virus type 1 gag gene that affect viral replication in the presence of cyclosporins , 1996, Journal of virology.

[47]  L. Arthur,et al.  Analysis and localization of cyclophilin A found in the virions of human immunodeficiency virus type 1 MN strain. , 1995, AIDS research and human retroviruses.

[48]  J. Sodroski,et al.  Functional association of cyclophilin A with HIV-1 virions , 1994, Nature.

[49]  J. Luban,et al.  Specific incorporation of cyclophilin A into HIV-1 virions , 1994, Nature.

[50]  B. Rosenwirth,et al.  Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog , 1994, Antimicrobial Agents and Chemotherapy.

[51]  Jeremy Luban,et al.  Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B , 1993, Cell.

[52]  J. Wills,et al.  Role of the avian retroviral protease in the activation of reverse transcriptase during virion assembly , 1991, Journal of virology.

[53]  J. Friedman,et al.  Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: One in the presence and one in the absence of CsA , 1991, Cell.

[54]  Stuart L. Schreiber,et al.  Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes , 1991, Cell.

[55]  H. Gendelman,et al.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.

[56]  D. Speicher,et al.  Cyclophilin: a specific cytosolic binding protein for cyclosporin A. , 1984, Science.

[57]  D. Baltimore,et al.  Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase , 1981, Journal of virology.